Price
221.4
-5.33%52W Range
Market Cap
₹435.66 Cr
Traded: ₹1.50 Cr (0.35%) 0.0x
Free Float: ₹156.14 Cr (0.96% of FF traded)
Volume · 60D trend
67 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| ROE | -- | -- | -- | -- | -- | -- |
| Sales | -- | -- | -- | -- | +45.0% | -- |
| Profit | -- | -- | -- | -- | +141.0% | -- |
| Return | -- | -- | -- | +90.0% | -- | -- |
Quarterly Results
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 48 | 45 | 46 | 45 | 36 | 35 | 33 | 31 | 23 | 24 | 20 |
| Expenses | 38 | 38 | 36 | 36 | 29 | 29 | 26 | 24 | 18 | 20 | 16 |
| Operating Profit | 9 | 8 | 10 | 9 | 7 | 6 | 7 | 7 | 5 | 4 | 4 |
| OPM % | 19.9% | 17.1% | 21.9% | 19.8% | 19.6% | 17.9% | 21.2% | 21.9% | 20.8% | 16.4% | 20.0% |
| Other Income | 1 | 1 | 1 | 1 | 1 | 4 | 1 | 1 | 1 | -0 | 1 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Profit Before Tax | 6 | 5 | 7 | 6 | 4 | 5 | 4 | 4 | 1 | -1 | 1 |
| Tax % | 25.3% | 20.2% | 27.3% | 25.7% | 25.7% | 32.3% | 25.7% | 27.4% | 0.0% | -70.8% | 102.9% |
| Net Profit | 4 | 4 | 5 | 4 | 3 | 4 | 3 | 3 | 1 | -0 | -0 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 2.2 | 2.0 | 2.8 | 2.1 | 1.6 | 1.8 | 1.4 | 1.4 | 0.7 | -0.1 | -0.0 |
| Sales Growth (YoY) | -- | 28.9% | 40.2% | 45.5% | 55.7% | 46.0% | 64.0% | -- | -- | -- | -- |
| Sales Growth (QoQ) | -- | -1.9% | 2.7% | 25.8% | 1.6% | 6.7% | 6.6% | 34.6% | -4.7% | 19.9% | -- |
| OP Growth (YoY) | 35.2% | 22.9% | 45.1% | 31.2% | 46.8% | 59.6% | 73.6% | -- | -- | -- | -- |
| OP Growth (QoQ) | 22.3% | -23.5% | 13.9% | 26.9% | 11.1% | -9.6% | 3.0% | 42.0% | 20.8% | -1.7% | -- |
| Profit Growth (YoY) | 36.9% | 9.2% | 102.2% | 47.4% | 115.2% | 1809.5% | 5460.0% | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | 9.3% | 102.2% | 46.9% | 114.9% | 1754.5% | 4633.3% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | -27.6% | 29.1% | 34.0% | -12.6% | 33.8% | -6.2% | 96.0% | 772.7% | -266.7% | -- |
| OP Margin | -- | 17.1% | 21.9% | 19.8% | 19.6% | 17.9% | 21.2% | 21.9% | 20.8% | 16.4% | 20.0% |
| Net Margin | -- | 8.7% | 11.8% | 9.4% | 8.7% | 10.2% | 8.2% | 9.2% | 6.3% | -0.9% | -0.3% |
| Material Cost % | 22.8% | 21.8% | 21.2% | 23.6% | 24.1% | 21.3% | 21.9% | 23.8% | 25.5% | 24.3% | 24.6% |
| Employee Cost % | 16.8% | 15.6% | 16.3% | 13.6% | 16.3% | 16.9% | 13.8% | 13.9% | 17.0% | 17.3% | 17.5% |
| P/S | 2.37 | 2.54 | 3.06 | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 24.49 | 26.22 | 30.09 | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 4.45 | 4.45 | 5.52 | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Asarfi Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/08/2026 ,inter alia, to consider and approve Notice is hereby given that ....
Submission of Newspaper Advertisement of unaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2026.
We wish to inform you that the board of Director of Asarfi Hospital Limited at its meeting held today, i.e, 07 August 2026, has considered and approved the unaudited standalone and consolidated ....
We hereby submit the Investor Presentation for the Qtr ended 30th June 2026.
Intimation Under Regulation 30 of the SEBI (Listing obligation and Disclosure Requirements) Regulations, 2015- Submission of Press Release/ Media Release.
We wish to inform you that the Board of Directors of Asarfi Hospital Limited ("the Company"), at its meeting held today, i.e., 07 August 2026, has considered and approved the Unaudited ....
Asarfi Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve of the Unaudited Financial ....
we wish to inform you that the Company will participate in an Analyst/Institutional Investor Meeting on dated July 24, 2026.
We hereby inform you that the Trading Window for dealing in the securities of the Company shall remain closed for all Designated persons and their Immediate Relative from July''01, 2026. ....
We wish to inform you that the Board of Directors of the Company at its meeting held today i.e., Saturday, 27 June 2026, commenced at 3:00 P.M. and concluded at 7:30 P.M., inter alia, considered ....
We hereby submit the transcript of the earning conference call held on May 27, 2026, wherein the Audited standalone and consolidated Financial Results of the company for the Qtr4 & Year ....
We wish you to inform you for the year ended March 31, 2026, There was no material deviation in the use of proceeds of issue of 5180000 Equity Share of face value of Rs.10 each, aggregating ....
Pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in continuation of our intimation dated May 21, 2026 regarding the schedule ....
With reference to our earlier intimation regarding the Analyst / Investor Meeting scheduled to be held on Monday, May 25, 2026, at 04:00 P.M. (IST), we wish to inform you that due to unavoidable ....
We wish to inform you that the Company has scheduled a Conference Call with Analysts / Investors on Monday, May 25, 2026 at 04:00 P.M. (IST), inter alia, to discuss the Audited Financial ....
We herewith a press release titled Extract of Audited Standalone and Consolidated financial Results of the Quarter and Year Ended March''31,2026 for your kind information and record.
We herewith a press release titled Extract of Audited Standalone and Consolidated financial Results of the Quarter and Year Ended March''31,2026 for your kind information and record.
We wish to inform you that the Board of Directors of Asarfi Hospital Limited at its meeting held today i.e. Monday, 11th May, 2026, has inter alia considered and approved the Audited Standalone ....
Intimation under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation 15 - Press Release Titled Extract of Audited Standalone and Consolidated Financial Results ....
Investor Presentation of Asarfi Hospital Limited for the Quarter and Financial Year ended 31st March, 2026.
We wish to inform you that the Board of Director of Asarfi Hospital Limited at its meeting held today i.e, Monday 11th May 2026, has inter alia considered and approved the standalone and ....
Asarfi Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/05/2026 ,inter alia, to consider and approve Pursuant to the aforesaid regulation, ....
In term of the provision of the securities and Exchange Board of India (PIT) Regulation,2015 as amended from to time and Prohibition of Insider trading policy ("the Policy").The Trading ....
Outcome of Press Release/Media Release Under Regulation 30 of SEBI ( Listing Obligation and Disclosure Requirements) Regulation, 2015.
With Reference the captioned subject, Press Release / Media Release title Extract of Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31,2025.
We Submission the Investor Presentation of the Company for the quarter ended December 31,2025.
We wish to inform you that the Board of Director of Asarfi Hospital Limited at its meeting held today i.e., 09-February''26 has considered and approved the unaudited standalone and consolidated ....
We wish to inform you that the Board of Directors of Asarfi Hospital Limited ('the Company'), at its meeting held today i.e. 09 February, 2026, has considered and approved the Unaudited ....
Asarfi Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 ,inter alia, to consider and approve Notice is hereby given that ....
Intimation for closure of Trading Window under security and exchange board of India (PIT) Regulation 2015.
We hereby inform you that the management of the company met with group of investor held by the Hem Securities Samrudhi 2025- Virtual SME Conclave through virtual mode on Thursday, December 4,2025.
This is to inform you that the Company will be meeting Investors/Analysts on dated November 04, 2025 organized by Hem Securities - Samrudhi 2025 Virtual SME Conclave.
We wish to inform you that the management of the Company will be participating in Samruddhi'2025(Season 2) - Nav Bharat ka Caravan Virtual Investor-Company Connect Conference organized ....
We hereby submit the transcript of the Earning Conference call held on November 19, 2025, wherein the Unaudited Standalone & Consolidated financial Results for the half year ended September ....
We hereby inform you that the Company participated in an Investor Meet (one-to-one meeting) organized by Chorus Call Conferencing Services (I) Pvt. Ltd. on November 19, 2025 through a virtual ....
We hereby inform you that on 17th November''2025 the Various department of Asarfi Hospital have been granted accreditation by the National Board of Examination in Medical Sciences (NBEMS).
We wish to inform you that the Company has scheduled a conference call with analysts/investors on Wednesday, November 19, 2025, at 4:00 PM IST, inter alia, to discuss the unaudited Financial ....
We wish you to inform you that the Board of Directors of Asarfi Hospital Limited at its meeting held on November 10,2025 has considered and approved the unaudited financial Results of the ....
We wish to inform you that the Board of Directors of Asarfi Hospital Limited ('the Company'), at its meeting held today, i.e., November 10, 2025, has considered and approved the Unaudited ....
Investor Presentation for Q2 & H1 OF FY 2025-26.
We Wish to inform you that the board of Director of Asarfi Hospital Limited at its meeting held today, i,e., November 10, 2025 has considered and approved the unaudited Standalone and Consolidated ....
We Wish to inform you that CRISIL Rating has issued its credit rating on the long term bank facilities of Asarfi Hospital Limited(the Company) the rating has been assigned at CRISIL BBB-/ Stable.
Intimation for closure of Trading Window under security and exchange board of India (Prohibition of Insider), Regulation, 2015.
We hereby inform you that the Board of Directors of the Company at their meeting held on September 25th 2025 pursuant to the recommendation of the Audit Committee, has approved the appointment ....
This is to inform you that in continuation of our earlier submission of the financial statement for the year ended March 31, 2025, it has come to our notice that the debtors ageing details ....
We hereby submit the details of the consolidated voting result of the business transacted at the 20th AGM of the Company held on Friday 12 September 12, 2025.
We wish you to inform you that the 20th Annual General Meeting (AGM) of the Members of Asarfi Hospital Limited was held on Friday, 12th September 2025 at 12: 00 pm at the registered office ....
We hereby submit the Annual Report of Asarfi Hospital Limited for the financial year 2024-25, including the Notice convening the Annual General Meeting.
We hereby inform you that the meeting of the Board of Directors of Asarfi Hospital Limited was held on Wednesday, August 20, 2025 at 03:00 P.M. at the registered office of the Company at ....
Asarfi Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/08/2025 ,inter alia, to consider and approve Asarfi Hospital Ltd has informed ....
Credit Ratings
6Concalls
6Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025May 2025
31 May 2025Jan 2025
31 Jan 2025Nov 2024
30 Nov 2024